Streetbeat News

Regulatory

LUNA

Luna Innovations announced a delay in the release of its Q4 results and stated that its previously issued unaudited financial statements for the quarters ended June 30, 2023, and September 30, 2023, should no longer be relied upon.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:39 pm

NCNA

NuCana's stock price increased following the grant of U.S. Patent #11925658 for phosphoramidate derivatives used in cancer treatment, particularly where patients show resistance.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:35 pm

NARI

Inari Medical, Inc. (NASDAQ: NARI) announced positive two-year interim results from the CLOUT registry for its ClotTriever system, presented at the American Venous Forum. The results show excellent safety, effectiveness, and long-term outcomes in treating deep vein thrombosis (DVT), with significantly lower post-thrombotic syndrome (PTS) rates compared to historical studies. Inari's commitment to high-level research, including the DEFIANCE trial, aims to establish ClotTriever and FlowTriever systems as the standard of care for DVT and pulmonary embolism patients.

Portfolio Pulse from Happy Mohamed

March 12, 2024 | 8:29 pm

INTT

inTEST announced it will restate its Q3 and first nine months of 2023 financial statements due to revenue deferral issues related to 'last time buys' of discontinued materials. This adjustment is expected to decrease Q3 revenue by $1.7 million and reduce earnings per diluted share from $0.24 to $0.19. The revenue deferral will also slightly impact Q4 2023 results, with revised expectations of $27.9 million in revenue and net earnings of $1.5 million, or $0.12 per diluted share.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:26 pm

VJET

Voxeljet AG (VJET) announced plans to voluntarily delist its ADSs from NASDAQ and deregister its ADS with the SEC to reduce expenses and strengthen its financial position. The company believes the costs and management demands of NASDAQ listing and SEC compliance do not justify the benefits. The delisting process will start with a Form 25 filing around March 22, 2024, followed by a Form 15 filing to deregister from the Exchange Act, with deregistration expected around April 1, 2024.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:18 pm

INTC

The Pentagon has decided to cancel its plan to allocate $2.5 billion in grants to Intel for semiconductor chip development, according to Bloomberg.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:18 pm

XME

U.S. lawmakers are set to introduce the Responsible Use of Seafloor Resources Act of 2024 to boost deep-sea mining and reduce reliance on China for critical minerals like nickel, manganese, and cobalt. The bill, led by Reps. Carol Miller and John Joyce, aims to provide financial, diplomatic, and infrastructural support for mining seafloor nodules. This move is in response to China's control over 60% of global critical mineral production and over 85% of refining capacity. The bill also addresses environmental concerns by including directives for comprehensive reports and analyses on the impact of deep-sea mining.

Portfolio Pulse from Piero Cingari

March 12, 2024 | 8:05 pm

NCNA

NuCana has been granted U.S. Patent #11925658 for 'Phosphoramidate Derivatives for Use in the Treatment of Cancer,' covering treatments for leukemia, prostate, lung, and breast cancers, especially in resistant cases.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:00 pm

DIA

QQQ

SPY

Major stock indexes have risen ahead of the market close, despite a Consumer Price Index (CPI) report that was slightly worse than anticipated.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 7:45 pm

SPY

Ken Griffin, CEO of Citadel, commented that the morning's inflation data was nearly in line with consensus expectations. He believes the Federal Reserve will be slower in adjusting rates than the market anticipates. Griffin also mentioned that the prospect of future rate cuts is currently driving the markets, and while Treasuries are not considered risky investments, their risk is often underappreciated.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 7:37 pm